Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is primarily known as a respiratory disease. The continued study of the disease has shown that long-term COVID-19 symptoms include persisting effects of the virus on the br...
Saved in:
| Main Authors: | Monica Costa, Da-Wei Wang, Kai-Dong Zhao, Lin Yuan, Anita Krisko, Jia-Yi Li, Tiago Outeiro, Wen Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10013-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1
by: Carme Fàbrega, et al.
Published: (2024-10-01) -
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)<subtitle>Working Group of 2019 Novel Coronavirus, Peking Union Medical College Hospital</subtitle>
by: Taisheng Li
Published: (2020-01-01) -
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
by: Ya-Nan Zhang, et al.
Published: (2020-01-01) -
Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01) -
Aged Lewis rats exposed to low and moderate doses of rotenone are a good model for studying the process of protein aggregation and its effects upon central nervous system cell physiology
by: Michael F. Almeida, et al.